
Overview
Yana G. Najjar, MD is a translational investigator and cutaneous oncologist at UPMC Hillman Cancer Center, where she also is an associate professor of medicine and Director of the Clinical and Translational Research Center. Dr. Najjar specializes in early phase clinical trials and in the treatment of advanced melanoma. Her research focusing on immunotherapy resistant melanoma and rare melanoma subtypes. She has developed multiple investigator-initiated trials that aim to remodel melanoma tumor cell metabolism and hypoxia in the tumor microenvironment to overcome mechanisms of resistance to immunotherapy. Her lab is focused on various correlative analyses from investigator-initiated trials. Dr. Najjar's research is funded by the NIH, the Department of Defense, and the Melanoma Research Alliance.
Dr. Najjar is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Melanoma, Metastatic Uveal Melanoma, Melanoma of the Eye, Renal Cell Carcinoma (RCC), and Gamma Knife Radiosurgery.
Dr. Najjar is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 58 peer reviewed articles and participating in 3 clinical trials. Dr. Najjar is currently accepting new patients.
Graduate Institution
Residency
Specialties
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5150 Centre Ave, Pittsburgh, PA 15232
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
Additional Areas of Focus
Dr. Najjar has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Office
Leonard Appleman is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Appleman is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.
AHN Cancer Institute-Med Onc & Infusions At Allegheny General Hospital
Nathan Bahary MD, PhD received his B.A. from Cornell University, an M.D. from the Cornell University School of Medicine, and his Ph.D. from the Rockefeller University. He completed his residency at Beth Israel Hospital in Boston. He did his postgraduate training at the Dana Farber Cancer Institute, Harvard, and Brigham and Women’s Hospital system before joining the faculty of UPMC as the Director of the Pancreatic Cancer Center. Since 2021, he is the Division Chief of Medical Oncology at AHN Cancer Institute and Director of AHNCI Clnical Research. Amongst his various appointments Dr. Bahary is a member of the NCI Pancreatic Task Force, the Eastern Cooperative Oncology Group (ECOG) where he serves on the ECOG GI Steering Committee and the American Society of Clinical Oncology (ASCO) His basic research interests lie in the intersection between gastrointestinal development, metabolic stress pathways, immunology, and cancer. He has a broad research background in cancer genetics, developmental biology, molecular biology, and clinical investigations, with specific training and expertise in key research areas broadly within the field of gastrointestinal oncology, and specifically within pancreatic cancer. Building on his work at Harvard Medical School, Dr. Bahary is using insights gained by studying vertebrate development to determine how cancers grow. Clinical trials emanating from this research will continue at AHN Cancer Institute and are expected to lead to the development of new targeted agents and immunologic strategies for treating cancer. Dr. Bahary is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Bahary is board certified in Medical Oncology, American Board Of Internal Medicine.
UPMC Presbyterian
Jason Luke is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Luke is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Melanoma, Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, and Liver Embolization.
Frequently Asked Questions about Dr. Yana Najjar
How do I make an appointment with Dr. Yana Najjar?
You can book an appointment with Dr. Yana Najjar by calling their office at 412-438-2744. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Yana Najjar a top-rated expert for Melanoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Yana Najjar is classified as an Elite expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Yana Najjar specialize in?
While Dr. Yana Najjar is a Oncology, they have specific expertise in Melanoma, Metastatic Uveal Melanoma, and Melanoma of the Eye. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Yana Najjar participate in research or clinical trials?
Yes. Dr. Yana Najjar has published 58 articles and abstracts on conditions like Melanoma. You can view a list of Dr. Yana Najjar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Yana Najjar accept my insurance?
Dr. Yana Najjar accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 412-438-2744 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- MelanomaDr. Najjar isElite. Learn about Melanoma.
- Advanced
- Melanoma of the EyeDr. Najjar isAdvanced. Learn about Melanoma of the Eye.
- Metastatic Uveal MelanomaDr. Najjar isAdvanced. Learn about Metastatic Uveal Melanoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Najjar isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Najjar isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Najjar isExperienced. Learn about Anal Cancer.
- Brain TumorDr. Najjar isExperienced. Learn about Brain Tumor.
- Choroid Plexus CarcinomaDr. Najjar isExperienced. Learn about Choroid Plexus Carcinoma.
- EGFR Positive Lung CancerDr. Najjar isExperienced. Learn about EGFR Positive Lung Cancer.
- Gamma Knife RadiosurgeryDr. Najjar isExperienced. Learn about Gamma Knife Radiosurgery.
- Large-Cell Lung CarcinomaDr. Najjar isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Najjar isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Najjar isExperienced. Learn about Lung Cancer.
- Metastatic Brain TumorDr. Najjar isExperienced. Learn about Metastatic Brain Tumor.
- Metastatic Pleural TumorDr. Najjar isExperienced. Learn about Metastatic Pleural Tumor.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Najjar isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Posterior Fossa TumorDr. Najjar isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Najjar isExperienced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Renal Cell Carcinoma (RCC)Dr. Najjar isExperienced. Learn about Renal Cell Carcinoma (RCC).
- Small Cell Lung Cancer (SCLC)Dr. Najjar isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Carcinoma of the Anal Canal (SCAC)
- Squamous Cell Lung CarcinomaDr. Najjar isExperienced. Learn about Squamous Cell Lung Carcinoma.
- Uveal MelanomaDr. Najjar isExperienced. Learn about Uveal Melanoma.
- Vaginal CancerDr. Najjar isExperienced. Learn about Vaginal Cancer.
